Legal Representation
Attorney
Jennifer Lee Taylor
USPTO Deadlines
Application History
15 events| Date | Code | Type | Description |
|---|---|---|---|
| May 9, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| May 9, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| May 9, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Oct 25, 2022 | CNFR | R | FINAL REFUSAL WRITTEN |
| Oct 25, 2022 | GNFR | O | FINAL REFUSAL E-MAILED |
| Oct 25, 2022 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Sep 23, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 22, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 22, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 22, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 22, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 22, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 16, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 30, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Aug 9, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical products, preparations, and substances for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; biological products, preparations, and substances in the nature of medical preparations for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; immunotherapies being medical preparations for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; vaccines; pharmaceuticals in the nature of biotechnology platform technology, namely, viral and vaccine vectors for delivery and insertion of function-altering genetic material into human and animal patients, plants, and crops, for visualization of specific cell types, for inducing humoral and cell-mediated responses, for targeting and killing cancer cells, for removing pathological functions, for controlling biological pests, and for boosting crop yields
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005